Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2004
11/04/2004US20040220393 Modulation of HIF1alpha and HIF2alpha expression
11/04/2004US20040220388 Novel heterodimeric fusion proteins
11/04/2004US20040220384 Novel ligand and dna thereof
11/04/2004US20040220132 Treatment of neurodegenerative disease through intracranial delivery of siRNA
11/04/2004US20040220131 administering an oligonucleotide antibody to reduce concentration of clustenin
11/04/2004US20040220130 Compact synthetic expression vector comprising double-stranded DNA molecules and methods of use thereof
11/04/2004US20040220129 Compositions and methods for siRNA inhibition of ICAM-1
11/04/2004US20040220128 Nucleic acid based modulation of female reproductive diseases and conditions
11/04/2004US20040220127 Methods and compositions relating to 5'-chimeric ribonucleic acids
11/04/2004US20040220123 therapy for bactericide infections which are drug resistance, antibiotic resistance; anticancer agents; hybrid nucleic acids;
11/04/2004US20040220107 Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins
11/04/2004US20040220106 Modified vitamin K-dependent polypeptides
11/04/2004US20040220098 Inhibin compositions and methods of enhancing fertility and growth
11/04/2004US20040220092 G-protein coupled receptors
11/04/2004US20040220088 Multiple domain glycoprotein hormones and methods of using
11/04/2004US20040220079 Inhibitors of Memapsin 2 and use thereof
11/04/2004US20040219693 Using labeled neomycin, immobilized on solid support to capture and detect RNA sequences; high-throughput screening
11/04/2004US20040219677 Synthetic genes and bacterial plasmids devoid of cpg
11/04/2004US20040219676 Methods and compositions for the introduction of molecules into cells
11/04/2004US20040219675 Nucleic acid molecules from rice encoding proteins for abiotic stress tolerance, enhanced yeild, disease resistance and altered nutritional quality and uses thereof
11/04/2004US20040219674 Virus envelope vector for gene transfer
11/04/2004US20040219673 Expression vector which utilizes site specific recombinases as insertion tools during in vivo and/or in vitro gene transfer
11/04/2004US20040219671 RNA interference mediated treatment of parkinson disease using short interfering nucleic acid (siNA)
11/04/2004US20040219667 Monoclonal antibody for human telomerase catalytic subunit
11/04/2004US20040219646 Process for producing nucleoside compound
11/04/2004US20040219645 Polyketides and their synthesis
11/04/2004US20040219644 Immunoglobulin for binding monocyte chemoattractant protein-1(MCP-1) and preventing and/or treating atherosclerosis and cancer ; antitumor agents
11/04/2004US20040219643 Dual-specific ligand
11/04/2004US20040219642 Using expression vector comprising nucleotide sequences coding interferon-specific transcriptional regulators and interferon receptors to transform cells and intensify expression of interferon; antiviral agents; antitumor agents
11/04/2004US20040219640 Polypeptides homologous to VEGFand BMPI
11/04/2004US20040219639 Immunogenic fusion polypeptide comprising lytic epitopes for use in developing vaccine for prevention of mastitis in dairy cattle; veterinary medicine; immunotherapy
11/04/2004US20040219638 Nucleic acids encoding beta 1,3-galactosyltransferases from C.jejuni
11/04/2004US20040219636 Aminopeptidase and the genes thereof
11/04/2004US20040219635 Degradation resistant antihypoxic agents for use in treatment and prevention of hypoxia and ischemic related tissue damage
11/04/2004US20040219634 Hybrid telomerase for generating gene transfer vector; gene therapy
11/04/2004US20040219633 Method of producing recombinant antibodies
11/04/2004US20040219632 T1r3 a novel taste receptor
11/04/2004US20040219631 Method for producing tripeptides and/or peptides longer than tripeptides
11/04/2004US20040219621 Test methods and devices
11/04/2004US20040219615 Antibody specific for a RAP-2 (RIP associated protein-2)of given sequence; mediating intracellular activity by introducing into cell DNA sequence encoding polypeptide in the form of a vector
11/04/2004US20040219614 Produced from a hybridoma prepared by fusing a mouse spleen and myeloma cell; detecting tumors; kits
11/04/2004US20040219595 Using RNA sequences to generate cDNA for use in medical diagnostics and forensics
11/04/2004US20040219585 Comprises nucleotide sequences coding bacterial outer membrane protein for use in diagnosis, treatment and prevention of infection; antisense bactericidal agent; microbiocides; immunoassy
11/04/2004US20040219583 Using splice variants of prostate specific antigen as diagnostic indicator of cell proliferative disorders
11/04/2004US20040219581 pH dependent signaling DNA enzymes
11/04/2004US20040219579 Identifying nucleic acid and protein expression profiles associated with cell proliferative and metabolic disorders; cancer associated proteins/transcripts and high throughput screening
11/04/2004US20040219575 Using presence of transcription factor/tumor antigen splice variant to diagnose cell proliferative disorders; tumor cell characterization
11/04/2004US20040219574 Comprises oligonucleotides for detection of gram-negative bacteria and/or lactobacillus in wort/infusions used in the preparation of malted alcoholic beverages; food processing
11/04/2004US20040219571 Genetically engineered RNA self replicating enzyme for use in removal of repetitve triplet codon associated with muscular dystrophy; gene therapeutics and RNA targeting
11/04/2004US20040219563 Determining timing of transcriptional activation or repression of genes associated cell differentiation; identifying temporal and spatial gene expression patterns that control differentiation of stem cells; tissue engineering and therapeutic transplantation
11/04/2004US20040219562 Novel form of the PHGPx protein as a diagnostic marker for male infertility
11/04/2004US20040219561 Phytic acid biosynthetic enzymes
11/04/2004US20040219551 Comprises nucleotide sequences coding epithelial stromal interaction 1 (EPSTI-1) protein for use in tumor diagnosis and identifying modulators for treatment of cell prolifefrative and viral disorders
11/04/2004US20040219548 Using presence of restriction fragment length polymorphisms in transforming growth factor, elastase, superoxide dismutase and tissue inhibitor of metalloproteinase gene or regulatory sequences to diagnose chronic obstructive pulmonary disease (COPD)
11/04/2004US20040219544 Amplification and detection of mycoplasma pneumoniae
11/04/2004US20040219543 Diagnosing tumor/disease associated cells in blood sample by transferring into cells vectors comprising reporter genes that are able to identify tumor and/or disease cell specific signaling activities; prognosing tumor metastasis
11/04/2004US20040219542 Identifying modulators of polyimmunoglubulin receptor (pIgR) and transfer of molecules from one surface of cell to another; endocytosis/exocytosis/transcytosis and enhanced drug delivery
11/04/2004US20040219541 Coimmobilizing biomolecules in a defined ratio on a substrate; conjugate oligonucleotides to polyethylene oxide and polypropylene oxide containing triblock or diblock copolymer, incubate, contact with substrate, conjugate with complimentary oligonucleotides, hybridize and recover nucleotide sequences
11/04/2004US20040219534 Rapid extraction of RNA from cells and tissues
11/04/2004US20040219527 Isolated luciferases and the use thereof
11/04/2004US20040219525 Expression vector coding farnesylation peptidase for use in transformation and generation of disease, freeze, drought and salt resistant plants; tissue engineering
11/04/2004US20040219524 Nucleotide sequences complimentary to 16s ribosomal RNA of escherichia and shigella for use in diagnosis of pathogen infection
11/04/2004US20040219522 Exson-intron junction determining device, genetic region determining device, and determining method for them
11/04/2004US20040219516 Expression vector comprising multiple recombination and/or topoisomerase sites for use as gene transfer tool in ptokaryotic and eukaryotic cells
11/04/2004US20040219515 Human immunodeficiency viral nucleotide sequences for use as gene therapeutic tools in prevention of viral infection; gene expression inhibition
11/04/2004US20040219228 inducing IBD-like symptoms in a transgenic mdr1a-/- knockout mouse by administering chlorinated drinking water; screening for genes involved in pathogenesis of IBD; gene expression profiling; microarray analysis; drug screening
11/04/2004US20040219170 Viruses encoding mutant membrane protein
11/04/2004US20040219168 Preparing preferential cells from blood mononucler cells in culture; obtain monocytes, incubate with interferon; use as biodrugs treating viral infections, lymphoma, neoplastic disease induced by Epstein-Barr virus, therapeutic vaccination
11/04/2004US20040219167 Herpes viruses for immune modulation
11/04/2004US20040219165 Streptococcus pneumoniae antigens
11/04/2004US20040219161 Include recombinant expression constructs containing nucleic acids encoding target cell surface receptor antigen and one or more immune response altering molecules, or the expressed products themselves
11/04/2004US20040219154 Monoclonal antibodies directed against hepatitis b viruses
11/04/2004US20040219151 Tetraspan protein and uses thereof
11/04/2004US20040219148 comprising an agent that targets an interleukin-15 receptor and a second agent that inhibits a costimulatory signal transmitted between a T cell and an antigen-presenting cell; treating autoimmune diseases, AIDS, vascular injuries or organ, tissue or cell transplant recipients
11/04/2004US20040219146 Prevention and treatment of amyloidogenic disease
11/04/2004US20040219131 Interferon-alpha polypeptides and conjugates
11/04/2004CA2526914A1 Compositions and methods relating to stop-1
11/04/2004CA2526887A1 Splice variants of human voltage-gated calcium channel alpha2delta-2 subunit designated-alpha2delta2-a and alpha2delta2-b
11/04/2004CA2523459A1 Method of accumulating allergen-specific t cell antigen determinant in plant and plant having the antigen determinant accumulated therein
11/04/2004CA2523452A1 Cancer specific monoclonal antibodies
11/04/2004CA2522904A1 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins
11/04/2004CA2522819A1 Polyvalent protein complex
11/04/2004CA2522730A1 Compositions and methods for sirna inhibition of angiopoietin 1 and 2 and their receptor tie2
11/04/2004CA2522718A1 A novel method of modulating bone-related activity
11/04/2004CA2522703A1 Prophylactic and therapeutic benefits of new class of immune stimulating peptides
11/04/2004CA2522560A1 Antisense modulation of apolipoprotein c-iii expression
11/04/2004CA2522497A1 Yeast ectopically expressing abnormally processed proteins and uses therefor
11/04/2004CA2522446A1 Compositions and methods for using a solid support to purify rna
11/04/2004CA2522364A1 Polymer-conjugated glycosylated neublastin
11/04/2004CA2522359A1 Pathotropic retroviral vector used to deliver diagnostic or therapeutic compositions
11/04/2004CA2522284A1 Method and devices for removal of organic molecules from biological mixtures
11/04/2004CA2522184A1 Desmoglein 4 is a novel gene involved in hair growth
11/04/2004CA2522172A1 Rhesus monkey bombesin receptor subtype-3 (brs-3), nucleotides encoding same, and uses thereof
11/04/2004CA2522081A1 Recombinant influenza viruses holding a mutation in a transmembrane protein gene
11/04/2004CA2520750A1 Orthogonal aminoacyl-trna synthetase
11/04/2004CA2520097A1 Truncated baff receptors
11/04/2004CA2519907A1 Method of inactivating ribonucleases at high temperature
11/04/2004CA2517010A1 Plasmid dna in combination with recombinant vsv for use in prime-boost immunization regimens
11/03/2004EP1473566A1 Methods for producing labeled nucleic acids or proteins
11/03/2004EP1473369A2 Compositions and methods for delivery of genetic material